Gastric cancer (GC) is a major public health issue as the fourth most common cancer and
the second leading cause of cancer-related death. Recent advances have improved our …

Gastric cancer is one of the leading causes of cancer-related deaths worldwide, although
the incidence has gradually decreased in many Western countries. Two main gastric cancer …

Background Gastric cancer is the fourth most common cancer in the world and the second
most prevalent cause of cancer related death. The development of gastric cancer is mainly …

Background: We have previously demonstrated that peroxisome proliferator-activated
receptor (PPARγ) activation inhibits hepatocarcinogenesis. We aim to investigate the effect …

Gastric cancer (GC) is still one of the most common causes of cancer-related death
worldwide, which is mainly attributable to late diagnosis and poor treatment options …

Gastric cancer is the most common malignant tumor in the digestive tract, with very high
morbidity and mortality in developing countries. The pathogenesis of gastric cancer is a …

Background Globally, gastric cancer is the second most common cause of cancer-related
death, with the majority of the health burden borne by economically less-developed …

Special AT-rich sequence binding protein 1 (SATB1), a new type of gene regulator, has
been reported to express in various human cancers and may associate with the malignant …

Transcription factor activating enhancer binding protein 4 (TFAP4) is established as a
regulator of human cancer genesis and progression. Overexpression of TFAP4 indicates …

RUNX2 is a bone‐specific transcription factor that plays a critical role in prenatal bone
formation and postnatal bone development. It regulates the expression of genes that are …